Sort   by:  
 Page size 
UnknownUnraveling the HIV-malaria interactions: a bibliometric analysis of global research trends and emerging insights.

Background

The co-infection of human immunodeficiency virus (HIV) and malaria has emerged as an urgent public health challenge in tropical areas where the two diseases geographically converge, stimulating extensive biomedical investigations into their pathobiological interactions. This study...
S-EPMC12426043 | biostudies-literature
UnknownCost-effectiveness of intermittent preventive treatment with dihydroartemisinin-piperaquine for malaria during pregnancy: an analysis using efficacy results from Uganda and Kenya, and pooled data.

Background

Prevention of malaria infection during pregnancy in HIV-negative women currently relies on the use of long-lasting insecticidal nets together with intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP). Increasing sulfadoxine-pyrimethamine resistan...
S-EPMC7686013 | biostudies-literature
UnknownThe impact of an intervention to introduce malaria rapid diagnostic tests on fever case management in a high transmission setting in Uganda: A mixed-methods cluster-randomized trial (PRIME).

Background

Rapid diagnostic tests for malaria (mRDTs) have been scaled-up widely across Africa. The PRIME study evaluated an intervention aiming to improve fever case management using mRDTs at public health centers in Uganda.

Methods

A cluster-randomized trial was conducted from 2010-...
S-EPMC5347994 | biostudies-literature
UnknownOptimal outcome measures for assessing exercise and rehabilitation approaches in chemotherapy-induced peripheral-neurotoxicity: Systematic review and consensus expert opinion.

Introduction

Chemotherapy-induced peripheral neurotoxicity (CIPN) remains a significant toxicity in cancer survivors without preventative strategies or rehabilitation. Exercise and physical activity-based interventions have demonstrated promise in reducing existing CIPN symptoms and potentia...
S-EPMC8963967 | biostudies-literature
UnknownSystemic inflammation is associated with malaria and preterm birth in women living with HIV on antiretrovirals and co-trimoxazole.
Women living with HIV (WLHIV) have an increased risk of malaria in pregnancy (MiP). It is unclear if MiP in WLHIV causes a systemic inflammatory response and increases the risk of adverse birth outcomes, especially for women receiving antiretroviral therapy (ART) and daily trimethoprim-sulfamethoxaz...
S-EPMC6494863 | biostudies-literature
UnknownRepurposing chemotherapy-induced peripheral neuropathy grading.

Background and purpose

Chemotherapy-induced peripheral neuropathy (CIPN) is perceived differently by patients and physicians, complicating its assessment. Current recommendations advocate combining clinical and patient-reported outcomes measures, but this approach can be challenging in patie...
S-EPMC11554987 | biostudies-literature
UnknownThe state of US health, 1990-2010: burden of diseases, injuries, and risk factors.

Importance

Understanding the major health problems in the United States and how they are changing over time is critical for informing national health policy.

Objectives

To measure the burden of diseases, injuries, and leading risk factors in the United States from 1990 to 2010 and to ...
S-EPMC5436627 | biostudies-literature
UnknownA comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
Not available
S-EPMC4156511 | biostudies-literature
UnknownGlobal, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
Not available
S-EPMC4340604 | biostudies-literature
UnknownPrehospital use of magnesium sulfate as neuroprotection in acute stroke.

Background

Magnesium sulfate is neuroprotective in preclinical models of stroke and has shown signals of potential efficacy with an acceptable safety profile when delivered early after stroke onset in humans. Delayed initiation of neuroprotective agents has hindered earlier phase 3 trials of...
S-EPMC4920545 | biostudies-literature
Sort   by:  
 Page size